1. Home
  2. SMTI vs AQST Comparison

SMTI vs AQST Comparison

Compare SMTI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$21.07

Market Cap

208.8M

Sector

Health Care

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.00

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTI
AQST
Founded
1982
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.8M
504.0M
IPO Year
2008
2007

Fundamental Metrics

Financial Performance
Metric
SMTI
AQST
Price
$21.07
$4.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$34.00
$9.00
AVG Volume (30 Days)
40.1K
1.7M
Earning Date
05-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$15,586,976.00
$67,430,000.00
Revenue This Year
$17.31
$10.08
Revenue Next Year
$12.48
$49.60
P/E Ratio
$425.20
N/A
Revenue Growth
32.47
0.77
52 Week Low
$16.05
$2.94
52 Week High
$35.70
$7.55

Technical Indicators

Market Signals
Indicator
SMTI
AQST
Relative Strength Index (RSI) 48.53 43.80
Support Level $18.20 $3.70
Resistance Level $21.26 $4.38
Average True Range (ATR) 1.21 0.19
MACD -0.20 -0.03
Stochastic Oscillator 14.41 11.97

Price Performance

Historical Comparison
SMTI
AQST

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: